BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain
CompletedNCT01186341
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Preliminary results from an ongoing cross-sectional survey of nine of the BraveNet Outpatient Clinics indicate that pain was the leading reason for patient visits. As a precursor to a large multi-site clinical trial, this study aims to determine the feasibility of collecting outcomes data on integrative treatment for pain. These preliminary data will also provide an estimation of effect size for powering the multi-site clinical trial.
Study details
- Official title
- BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain
- Conditions
- Sponsor
- Duke University
- Collaborators
- The Bravewell Collaborative; Alliance Institute for Integrative Medicine; Allina Health System; University of Maryland; Beth Israel Medical Center; Thomas Jefferson University; University of California, San Francisco; Scripps Clinic; Venice Family Clinic
- Start date
- 2009-06
- Primary completion
- 2011-06
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 9
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Subjects will be men and women aged 18 and over. * Patient Status: Participants are eligible if they are new or existing patients of the center who are seeking their initial treatment at the Integrative Medicine center for chronic pain (chronic \> 3 months) who report their average pain level over the past month to be at least a 4 of 10 on the VAS. * English or Spanish Literacy: Ability to read and write English or Spanish as confirmed by the site personnel and ability to provide informed consent. * Subject must provide written informed consent before initiation of any study-related procedures. * Subject must be able to understand and comply with the requirements of the study, as judged by the investigator. Exclusion Criteria: * A subject will not be eligible if he/she is unable to provide Informed Consent. * Inability to read and write in English or Spanish. * Any condition which could interfere with, or the treatment for which might interfere with, the conduct of the study or which would, in the opinion of the Investigator, unacceptably increase the patients risk by participating in the study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01186341